Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

0.48
Delayed Data
As of Mar 24
 +0.05 / +11.63%
Today’s Change
0.33
Today|||52-Week Range
1.10
-11.11%
Year-to-Date
No recent news for Oragenics Inc.

Today’s Trading

Previous close0.43
Today’s open0.45
Day’s range0.44 - 0.50
Volume51,727
Average volume (3 months)122,804
Market cap$23.7M
Dividend yield--
Data as of 3:49pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+40.69%
Earnings growth (this year)-21.05%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book7.87

Competitors

 Today’s
change
Today’s
% change
VICLVical Inc+0.02+0.94%
ABIOARCA Biopharma Inc+0.15+6.00%
HTBXHeat Biologics Inc-0.00-0.12%
IMNPImmune Pharmaceutica...-0.01-8.62%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$8.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alan F. Joslyn
Chief Financial Officer, Secretary &
Treasurer
Michael O'Keefe Sullivan
Corporate headquarters
Tampa, Florida

Forecasts


Search for Jobs